Mr. Speaker, indeed we were. As I suggested during my speech, particularly with respect to the definition of “distinctive”, as it was rewritten in the bill, it was imperative that we return to the original so that it would be possible for people to have confidence in generic drugs and that we were not inadvertently affecting people's health and safety by making a change in the bill for which there was no demonstrable reason.
One of the things that was really fascinating to me during the committee's deliberations on the bill was the magnitude of counterfeit goods that have been coming into the country. We learned, for example, that many of the counterfeit Canada Goose goose-down jackets have chicken feces and chicken beaks instead of just down in the coats. We heard of batteries exploding and the deaths of police officers. I did not know that when one buys a Team Canada hockey jersey, the way to know whether it is a fake or it is real is to check to see if it was made in Canada. If the jersey was made in Canada, it is actually a fake.
There are all kinds of consumer issues that we need to address in a very serious way, and frankly, we need to do much more consumer education as well so that we can detect, as consumers, which goods are officially licensed and which ones are counterfeit.